Group 1 - The company held its first extraordinary general meeting of shareholders on January 16, 2026, at a designated location in Shanghai [5] - The meeting was convened by the board of directors and chaired by Chairman Fei Jian, utilizing a combination of on-site and online voting methods, in compliance with relevant laws and regulations [2][4] - All 11 current directors and the board secretary attended the meeting, along with other senior management personnel [3] Group 2 - A key resolution regarding participation in the investment of the Qiyuan Phase I Fund and related transactions was approved during the meeting [4] - The voting results indicated that the resolution was passed with more than half of the voting rights held by attending shareholders [4] - The meeting was legally witnessed by Beijing Tongshang Law Firm, confirming that the procedures and voting were in accordance with legal and regulatory requirements [6]
上海南方模式生物科技股份有限公司2026年第一次临时股东会决议公告